Loracarbef versus Phenoxymethylpenicillin in the Treatment of Recurrent Streptococcal Pharyngotonsillitis

References

• Roos K, Holm S E, Ekedahl C. Treatment failure in acute streptococcal tonsillitis in children over age of ten and in adults. Clinical and therapeutical aspects. Scand J Infect Dis 1985; 17: 357–365
   PubMedGoogle Scholar
• Strömberg A, Schwan A, Cars O. Five versus ten days treatment of group A streptococcal pharyngotonsillitis: a randomized controlled clinical trial with phenoxymethylpenicillin and cefadroxil. Scand J Infect Dis 1988; 20: 37–46
   PubMed Web of Science ®Google Scholar
• Schwartz R H, Wientzen R L, Pedreira F, Feroli E, Mella G, Guandolo V. Penicillin V for group A streptococcal pharyngotonsillitis. JAMA 1981; 246: 1790–1795
   PubMed Web of Science ®Google Scholar
• Roos K, Holm S E, Grahn E, Lind L. α-streptococci as supplementary treatment of recurrent streptococcal tonsillitis. A randomized placebo controlled study. Scand J Infect Dis 1993; 25: 31–35
   PubMed Web of Science ®Google Scholar
• Roos K, Grahn E, Holm S E. Evaluation of b˜-lactamase activity and microbial interference in treatment failures of acute streptococcal tonsillitis. Scand J Infect Dis 1986; 18: 13–19
   Google Scholar
• Brook I, Yocum P, Calhoun L. b˜-Lactamase producing Bacteroides species recovered from children. Possible clue to failure of penicillin treatment. Lancet 1981; 1: 332
   PubMed Web of Science ®Google Scholar
• Brook I. The role of b˜-lactamase producing bacteria in the persistence of streptococcal tonsillar infection. Rev Infect Dis 1984; 6: 601–607
   PubMedGoogle Scholar
• Grahn E, Holm S E, Roos K. Penicillin tolerance in b˜-streptococci isolated from patients with tonsillitis. Scand J Infect Dis 1987; 19: 421–426
   PubMed Web of Science ®Google Scholar
• Grahn E, Holm S E. Bacterial interference in the throat flora during a streptococcal tonsillitis outbreak in an apartment house area. Zbl Bakt Hyg A 1983; 256: 72–79
   PubMedGoogle Scholar
• Pichichero M. The rising incidence of penicillin treatment failures in group A sreptococcal tonsillopharyngitis: an emerging role for the cephalosporins?. Scand J Infect Dis 1991; 10: 50–55
   Google Scholar
• Olsson-Liljequist B, Burman L, Kallings I, The S, wedish Respiratory T, ract Study Group. Antibiotic susceptibility of upper respiratory tract pathogens in Sweden: A seven year follow-up study including loracarbef. Scand J Infect Dis 1992; 24: 485–493
   PubMed Web of Science ®Google Scholar
• McCarty J. Loracarbef versus Penicillin VK in the treatment of streptococcal pharyngitis and tonsillitis in an adult population. Am J Med 1992; 92: 74–79, Suppl 6A
   Google Scholar
• Disney F A, Hanfling M J, Hausinger S A. Loracarbef (LY163892) vs. penicillin VK in the treatment of streptococcal pharyngitis and tonsillitis. Pediatr Infect Dis J 1992; 11: S20–S26
   PubMed Web of Science ®Google Scholar
• Facklam R R, Washington J A. Streptococcus and related catalase-negative Gram-positive cocci. Manual of clinical microbiology, 5th ed., A Balows, W J Hausler, K L Herrman, H D Isenberg, H J Shadomy. American Society for Microbiology, Washington, DC 1991; 238–257
   Google Scholar
• Maxted W, Widdowson J P. The protein antigens of group A streptococci:. Streptococci and streptococcal diseases, L W Wannamaker, J M Matsen. Academic Press, New York 1972; 251–264
   Google Scholar
• Holm S, Henning C, Grahn E, Lomberg H, Staley H. Is penicillin the appropriate treatment for recurrent tonsillopharyngitis? Results from a comparative randomized blind study of cefuroxime axetil and phenoxymethylpenicillin in children. Scand J Infect Dis 1995; 27: 221–228
   PubMed Web of Science ®Google Scholar
• Orrling A, Stjernqvist-Desatnik A, Schalén C, Kamme C. Clindamycin in persisting pharyngotonsillitis after penicillin treatment. Scand J Infect Dis 1994; 20: 535–541
   Google Scholar
• Brook I. Treatment of patients with acute recurrent tonsillitis due to group A b˜-haemolytic streptococci: a prospective randomized study comparing penicillin and amoxycillin/clavulanic potassium. J Antimicrob Chemother 1989; 24: 227–233
   PubMed Web of Science ®Google Scholar
• Nord C E, Grahnen A, Eckernäs S-Å. Effect of loracarbef on the normal oropharyngeal and intestinal microflora. Scand J Infect Dis 1991; 23: 255–260
   PubMed Web of Science ®Google Scholar
• Neu H. The crisis in antibiotic resistance. Science 1992; 257: 1064–1073
   PubMed Web of Science ®Google Scholar